Methodological aspects of flow cytometry DNA analysis in endometrial carcinoma, with special reference to sampling and reproducibility

Acta Oncologica

Volumn 35, Issue 8, 1996, Pages 999-1006

  Gudmundsson, Thorkell E ^a   Långström, Eva ^a   Alm, Per ^a   Anderson, Harald ^a   Baldetorp, Bo ^a   Fernö, Mårten ^a   Högberg, Thomas ^a   Killander, Dick ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CELL CYCLE S PHASE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; PLOIDY; PRIORITY JOURNAL; REPRODUCIBILITY; SAMPLING;

EID: 0030483322     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.3109/02841869609100718     Document Type: Article

References (31)

1. Hedley BW, Friedlander ML, Taylor IW, et al. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem 1983; 31: 1333-5.
2. Schutte B, Reynders M, Bosman F. Blijham G. Flow cytometric determination of ploidy level in nuclei isolated from paraffin-embedded tissue. Cytometry 1985; 6: 26-30.
3. Heiden T, Wang N, Tribukait B. An improved Hedley method for preparation of paraffin embedded tissues for flow cytometric analysis of ploidy and S-phase. Cytometry 1991; 12: 614-21.
4. Iversen OE. Flow cytometric deoxyribonucleic acid index: A prognostic factor in endometrial carcinoma. Am J Obstet Gynecol 1986; 155: 770-6.
5. Lindahl B, Alm P, Fernö M, et al. Prognostic value of flow cytometric DNA measurements in stage I-II endometrial carcinoma: Correlation with steroid receptor concentration, tumor myometrial invasion and degree of differentiation. Anticancer Res 1987; 7: 791-8.
6. Geisinger KR, Homesley HO, Morgan TM, Kute TE, Marshal RB. Endometrial adenocarcinoma. A multiparameter clinicopathologic analyses including DNA profile and sex steroid hormone receptors. Cancer 1986; 58: 1518-25.
7. Stendahl U, Strang P, Wagenius G, Bergström R, Tribukait B. Prognostic significance of proliferation in endometrial adenocarcinoma: A multivariate analysis of clinical and flow cytometric variables. Int J Gynecol Pathol 1991; 10: 271-84.
8. Minckwitz G, Kuhn W, Kaufmann M, et al. Prognostic importance of DNA-ploidy and S-phase fraction in endometrial cancer. Int J Gynecol Cancer 1994; 4: 250-6.
9. Friberg LG, Norén H. Delle U. Prognostic value of DNA ploidy and S-phase fraction in endometrial cancer stage I and II: a prospective 5-year survival study. Gynecol Oncol 1994; 53: 64-9.
10. Susini T, Rapi S, Savino L, Boddi V, Berti P, Massi G. Prognostic value of flow cytometric deoxyribonucleic acid index in endometrial carcinoma: comparison with other clinical-pathologic parameters. Am J Obstet Gynecol 1994; 170: 527-34.
11. Wagenius G, Bergström R, Strang P, et al. Prognostic significance of flowcytometric and clinical variables in endometrial adenocarcinoma stages I and II. Anticancer Res 1992; 12: 725-32.
12. Moberger B, Auer G, Forslund G. Moberger G. The prognostic significance of DNA measurements in endometrial carcinoma. Cytometry 1984; 5: 430-6.
13. Sorbe B, Risberg B, Frankendahl B. DNA ploidy, morphometry and nuclear grade as prognostic factors in endometrial carcinoma. Gynecol Oncol 1990; 38: 22-7.
14. Rosenberg P, Wingren S, Simonsen E, Stål O, Risberg B, Nordenskjöld B. Flow cytometric measurements of DNA index and S-phase on paraffin-embedded early stage endometrial cancer: An important prognostic indicator. Gynecol Oncol 1989; 35: 50-4.
15. Britton LC, Wilson TO, Gaffey TA, Lieber MC, Wicand HS, Podratz K. Flow cytometric DNA-analysis of stage I endometrial carcinoma. Gynecol Oncol 1989; 34: 317-22.
16. Konski AA, Myles JL, Sawyer, et al. Flow cytometric DNA content analyses of paraffin block embedded endometrial carcinomas. Int J Radiat Oncol Biol Phys 1991; 21: 1033-9.
17. Nowbury R, Schuerch C, Goodspeed N, Fanning J, Glidewell O, Evans M. DNA content as a prognostic factor in endometrial carcinoma. Obstet Gynecol 1990; 76: 251-7.
18. Goodman A, Bell DA, Rice LW. DNA ploidy status: its impact on early-stage endometrial adenocarcinoma. Gynecol Oncol 1993; 51: 355-61.
19. Coleman RL, Schink JC, Miller DS, et al. DNA flow cytometric analysis of clinical stage 1 endometrial carcinomas with lymph node metastases. Gynecol Oncol 1993; 50: 20-4.
20. Fernö M, Baldetorp B, Ewers SB, et al. One or multiple sampling for flow cytometric DNA analysis in breast cancer-Prognostic implications? Cytometry 1991; 13: 1-9.
21. Wingren S, Hatschek T, Stål O, Boeryd B, Nordenskjöld B. Comparison of static and flow cytofluorometry for estimation of DNA-index and S-phase fraction in fresh frozen and paraffin embedded breast carcinoma tissue. Acta Oncol 1988; 27: 793-7.
22. Kallioniemi OP. Comparison of fresh and paraffin embedded tissue as starting material for DNA flow cytometry and evaluation of intratumor heterogeneity. Cytometry 1988; 9: 164-9.
23. Risberg B. Stål O, Bjelkenkrantz K, et al. Use of formalin fixed, paraffin embedded tumors for estimation of cellular DNA content and S-phase fraction by static cytofluorometry. Acta Radiol Oncol 1985; 24: 537-44.
24. Kute TE, Gregory B, Galleshow J. Hopkins M, Bass D, Case D. How reproducible are flow cytometry data from paraffin embedded blocks. Cytometry 1988; 9: 494-8.
25. Ewers S, Attewell R, Baldetorp B, Borg Å. Långström E, Killander D. Prognostic potential of flow cytometric S-phase and ploidy prospectively determined in primary breast carcinomas. Breast Cancer Res Treat 1991; 20: 93-100.
26. Baldetorp B, Dalberg M, Holst U, Lindgren G. Statistical evaluation of cell kinetic data from DNA flow cytometry (FCM) by the EM algorithm. Cytometry 1989; 10: 695-705.
27. Hiddemann W, Schumann J, Andreeff M, et al. Convention of nomenclature for DNA Cytometry 1984; 5: 445-6.
28. Baldetorp B, Bendahl PO, Fernö M, et al. Reproducibility in DNA flow cytometric analysis of breast cancer: Comparison of 12 laboratories results for 67 sample homogenates. Comm Clin Cytometry 1995; 22: 115-27.
29. Alvegård T, Berg N, Baldetorp B, et al. Cellular DNA content and prognosis of high-grade soft tissue sarcoma: The Scandinavian sarcoma group experience. J Clin Oncol 1990; 8: 538-47.
30. Dressler LG, Seamer LC, Owens MA, Clark GM, McGuire WL. DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens. Cancer 1988; 61: 420-7.
31. Hedley DW. Flow cytometry using paraffin-embedded tissue: five years on. Cytometry 1989; 10: 229-241.